AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MAYNE PHARMA GROUP LTD

3.000

-0.030-0.99%

Volume:83.80K

Turnover:252.73K

Market Cap:245.67M

PE:14.45

High:3.050

Open:3.050

Low:2.995

Close:3.030

52wk High:6.500

52wk Low:2.040

Shares:81.89M

Float Shares:67.00M

Volume Ratio:0.25

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.208

EPS(LYR):0.208

ROE:8.20%

ROA:-1.73%

PB:0.63

PE(LYR):14.45

Loading ...

Overview Company News Filings

Mayne Pharma Group Ltd - Mayne Pharma Receives a$14.4M Payment for Legal Costs From Cosette

THOMSON REUTERS

Mayne Pharma's Unit Signs First Third-Party Partnership With Resilia Pharmaceuticals

MT Newswires Live

Mayne Pharma Group - Distributerx to Exclusively Distribute Recedo Gel for Resilia Pharmaceuticals

THOMSON REUTERS

Mayne Pharma Group - Distributerx to Receive Fixed Fee per Recedo Prescription Filled

THOMSON REUTERS

BUZZ-Australia's Mayne Pharma jumps after legal cost award

New South Wales Supreme Court Awards Mayne Pharma Group Over AU$13 Million in Legal Costs Following Cosette Pharmaceuticals Proceedings; Shares Up 6%

MT Newswires Live

3 ASX Penny Stocks With Market Caps Over A$70M To Consider

Simply Wall St.

Mayne Pharma Group Ltd - Court Is Expected to Make Orders to Give Effect to Judgement Shortly

THOMSON REUTERS

Mayne Pharma Group Ltd - All Figures in AUD

THOMSON REUTERS

Mayne Pharma Group to Expand Wholly-Owned Specialty Pharmacy in Kentucky

MT Newswires Live

Mayne Pharma Group Ltd-Mayne Pharma Announces Expansion of Adelaide Apothecary

THOMSON REUTERS

BRIEF-Mayne Pharma Provides Further Details On Equity Instruments To Be Issued To CEO

Mayne Pharma - Confirms That CEO Is Not Involved in Any Remuneration Decisions Regarding Issue of Incentives to Him

THOMSON REUTERS

Mayne Pharma Group Ltd-Further Details Re Equity Instruments to Be Issued to CEO

THOMSON REUTERS

BRIEF-Mayne Pharma Posts QTRLY Underlying EBITDA Of -A$1.4 Million

Mayne Pharma Group Reports Higher Fiscal Q3 Revenue

MT Newswires Live

Stock Track | Mayne Pharma Group Soars 5.58% Intraday on Strong Revenue, Tariff Immunity and Buy-Back Plans

Mayne Pharma Group Ltd: No Material Earnings Impact From US Tariff Proclamation on 7 April

THOMSON REUTERS

Mayne Pharma Group - Continues to Examine Capital Allocation Strategies, May Include on-Market Share Buy-Back

THOMSON REUTERS

Maywood Acquisition Closes $100 Million IPO

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/MYX.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"MYX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","market":"AU","secType":"STK","nameCN":"MAYNE PHARMA GROUP LTD","latestPrice":3,"timestamp":1789539120000,"preClose":3.03,"halted":0,"volume":83795,"delay":0,"changeRate":-0.009900990099009837,"nameEN":"MAYNE PHARMA GROUP LTD","floatShares":66997185,"shares":81890887,"eps":0.207588,"marketStatus":"Closed","change":-0.03,"latestTime":"09-16 16:12:00 AEST","open":3.05,"high":3.05,"low":2.995,"amount":252732,"amplitude":0.018152,"askPrice":3.06,"askSize":766,"bidPrice":3,"bidSize":3298,"shortable":3,"etf":0,"ttmEps":0.207588,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":3.03,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0.249674,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MYX.AU","preClose":3.03,"auctionPrice":3,"auctionVolume":1271,"auctionTime":1789539004933,"referencePrice":3,"referenceTime":1789549200934,"auction":3,"marketStatus":"盘后竞价","timestamp":1789539004933}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","floatShares":66997185,"roa":"-1.73%","roe":"8.20%","lyrEps":0.207588,"volumeRatio":0.249674,"shares":81890887,"dividePrice":0,"high":3.05,"amplitude":0.018152,"preClose":3.03,"low":2.995,"week52Low":2.04,"pbRate":"0.63","psRate":"0.64","week52High":6.5,"institutionHeld":0,"latestPrice":3,"committee":0.623031,"eps":0.207588,"divideRate":0,"volume":83795,"delay":0,"ttmEps":0.207588,"open":3.05,"prevYearClose":3.11,"prevWeekClose":2.96,"prevMonthClose":3.1,"prevQuarterClose":2.79,"fiveDayClose":3.18,"twentyDayClose":3.23,"sixtyDayClose":2.38,"dividendPayoutRate":0.04569711225089115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.014818181818181815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787788800000,"name":null,"time":"","dateTimestamp":1787752800000,"actualEps":null},{"date":"2026-02-22","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771714800000,"name":null,"time":"","dateTimestamp":1771678800000,"actualEps":null},{"date":"2025-08-29","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756425600000,"name":null,"time":"","dateTimestamp":1756389600000,"actualEps":null},{"date":"2025-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-23","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724371200000,"name":null,"time":"","dateTimestamp":1724335200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYX.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-01-18","recordDate":"2023-01-19","paymentDate":"2023-01-27","value":0.038,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MYX.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2641956251","title":"Mayne Pharma Group Ltd - Mayne Pharma Receives a$14.4M Payment for Legal Costs From Cosette","url":"https://stock-news.laohu8.com/highlight/detail?id=2641956251","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641956251?lang=en_us&edition=fundamental","pubTime":"2026-06-05 08:45","pubTimestamp":1780620308,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nFWN42C0LO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640981347","title":"Mayne Pharma's Unit Signs First Third-Party Partnership With Resilia Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2640981347","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640981347?lang=en_us&edition=fundamental","pubTime":"2026-06-01 08:16","pubTimestamp":1780273009,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  said its DistributeRx unit has entered into its first third-party partnership with Resilia Pharmaceuticals to exclusively distribute Recedo topical gel through DistributeRx's prescription distribution platform, according to a Monday Australian bourse filing.The company said DistributeRx will receive a fixed fee for each Recedo prescription filled using the platform.The topical gel is intended for the management of old and new hypertrophic or keloid scarring resulting from burns, surgical procedures or trauma wounds, the filing added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7096","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640986016","title":"Mayne Pharma Group - Distributerx to Exclusively Distribute Recedo Gel for Resilia Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2640986016","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640986016?lang=en_us&edition=fundamental","pubTime":"2026-06-01 06:50","pubTimestamp":1780267827,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nFWN428033:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","MYX.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640860159","title":"Mayne Pharma Group - Distributerx to Receive Fixed Fee per Recedo Prescription Filled","url":"https://stock-news.laohu8.com/highlight/detail?id=2640860159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640860159?lang=en_us&edition=fundamental","pubTime":"2026-06-01 06:50","pubTimestamp":1780267827,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nFWN428033:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637360942","title":"BUZZ-Australia's Mayne Pharma jumps after legal cost award","url":"https://stock-news.laohu8.com/highlight/detail?id=2637360942","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637360942?lang=en_us&edition=fundamental","pubTime":"2026-05-22 12:51","pubTimestamp":1779425506,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mayne Pharma jumps after legal cost award** Mayne Pharma's MYX.AX shares jump as much as 8.1% to A$2.55, marking their biggest intraday gain since April 29, on track for a third strai","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nL6N41Z08R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637628443","title":"New South Wales Supreme Court Awards Mayne Pharma Group Over AU$13 Million in Legal Costs Following Cosette Pharmaceuticals Proceedings; Shares Up 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637628443","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637628443?lang=en_us&edition=fundamental","pubTime":"2026-05-22 11:09","pubTimestamp":1779419376,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  is entitled to nearly AU$13.3 million in legal costs following court proceedings against Cosette Pharmaceuticals in the New South Wales Supreme Court last year, according to a Friday filing with the Australian bourse.The company initiated proceedings against Cosette Pharmaceuticals in June 2025 in relation to Cosette's purported termination of the scheme implementation deed signed by the two parties in February 2025, the filing said.The court ruled in favor of the company in October 2025 and made an adverse costs order against Cosette, per the filing.Mayne Pharma Group shares rose 6% in midday trade on Friday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MYX.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637139346","title":"3 ASX Penny Stocks With Market Caps Over A$70M To Consider","url":"https://stock-news.laohu8.com/highlight/detail?id=2637139346","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637139346?lang=en_us&edition=fundamental","pubTime":"2026-05-22 10:09","pubTimestamp":1779415747,"startTime":"0","endTime":"0","summary":"It’s looking like we could be in for a green finish to the week with ASX futures tipping a rise of 0.5% for the ASX pre-market after oil prices dipped again overnight and gold travelled back above US$4,500 an ounce. While 'penny stocks' might seem like an outdated term, they continue to offer intriguing possibilities for investors seeking affordable entry points and growth potential. In this article, we highlight three penny stocks that showcase financial strength and resilience, offering...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/3071000-choice2-main-header/1585186751359","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3071000-choice2-main-header/1585186751359"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/capital-goods/asx-mxi/maxiparts-shares/news/3-asx-penny-stocks-with-market-caps-over-a70m-to-consider","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/capital-goods/asx-mxi/maxiparts-shares/news/3-asx-penny-stocks-with-market-caps-over-a70m-to-consider","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7077","MYX.AU","BK7096","BK7062","BK7508","MXI.AU","CAF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637661653","title":"Mayne Pharma Group Ltd - Court Is Expected to Make Orders to Give Effect to Judgement Shortly","url":"https://stock-news.laohu8.com/highlight/detail?id=2637661653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637661653?lang=en_us&edition=fundamental","pubTime":"2026-05-22 09:08","pubTimestamp":1779412127,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nTUE6MPXLJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637366157","title":"Mayne Pharma Group Ltd - All Figures in AUD","url":"https://stock-news.laohu8.com/highlight/detail?id=2637366157","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637366157?lang=en_us&edition=fundamental","pubTime":"2026-05-22 09:08","pubTimestamp":1779412127,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nTUE6MPXLJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636017673","title":"Mayne Pharma Group to Expand Wholly-Owned Specialty Pharmacy in Kentucky","url":"https://stock-news.laohu8.com/highlight/detail?id=2636017673","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636017673?lang=en_us&edition=fundamental","pubTime":"2026-05-18 08:50","pubTimestamp":1779065418,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group's (ASX:MYX) wholly-owned specialty pharmacy, Adelaide Apothecary, will relocate and expand its fulfillment operations to a new facility in Lexington, Kentucky, according to a Monday","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","MYX.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636148530","title":"Mayne Pharma Group Ltd-Mayne Pharma Announces Expansion of Adelaide Apothecary","url":"https://stock-news.laohu8.com/highlight/detail?id=2636148530","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636148530?lang=en_us&edition=fundamental","pubTime":"2026-05-18 06:57","pubTimestamp":1779058664,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260517:nTUE2X9MQ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631574153","title":"BRIEF-Mayne Pharma Provides Further Details On Equity Instruments To Be Issued To CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2631574153","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631574153?lang=en_us&edition=fundamental","pubTime":"2026-04-30 09:45","pubTimestamp":1777513500,"startTime":"0","endTime":"0","summary":"BRIEF-Mayne Pharma Provides Further Details On Equity Instruments To Be Issued To CEOApril 30  - Mayne Pharma Group Ltd MYX.AX:FURTHER DETAILS RE EQUITY INSTRUMENTS TO BE ISSUED TO CEOCONFIRMS THAT CEO IS NOT INVOLVED IN ANY REMUNERATION DECISIONS REGARDING ISSUE OF INCENTIVES TO HIMFurther company coverage: MYX.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUE8K62YS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","MYX.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631752031","title":"Mayne Pharma - Confirms That CEO Is Not Involved in Any Remuneration Decisions Regarding Issue of Incentives to Him","url":"https://stock-news.laohu8.com/highlight/detail?id=2631752031","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631752031?lang=en_us&edition=fundamental","pubTime":"2026-04-30 06:23","pubTimestamp":1777501382,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nTUE8K62YS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631312520","title":"Mayne Pharma Group Ltd-Further Details Re Equity Instruments to Be Issued to CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2631312520","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631312520?lang=en_us&edition=fundamental","pubTime":"2026-04-30 06:23","pubTimestamp":1777501382,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nTUE8K62YS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631556330","title":"BRIEF-Mayne Pharma Posts QTRLY Underlying EBITDA Of -A$1.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631556330","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631556330?lang=en_us&edition=fundamental","pubTime":"2026-04-29 09:23","pubTimestamp":1777425830,"startTime":"0","endTime":"0","summary":"BRIEF-Mayne Pharma Posts QTRLY Underlying EBITDA Of -A$1.4 MillionApril 29  - Mayne Pharma Group Ltd MYX.AX:QTRLY  UNDERLYING EBITDA OF -A$1.4 MILLIONNO MATERIAL EARNINGS IMPACT FROM US TARIFF PROCLAMATION ON 7 APRILQTRLY REVENUE A$85.2 MILLIONCONTINUES TO EXAMINE CAPITAL ALLOCATION STRATEGIES, MAY INCLUDE ON-MARKET SHARE BUY-BACKFurther company coverage: MYX.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41B152:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631553185","title":"Mayne Pharma Group Reports Higher Fiscal Q3 Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2631553185","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631553185?lang=en_us&edition=fundamental","pubTime":"2026-04-29 08:41","pubTimestamp":1777423296,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  reported unaudited fiscal third-quarter revenue of AU$85.2 million, up 1% from AU$84.3 million a year earlier, according to a Wednesday filing with the Australian bourse.The company also reported underlying loss before interest, taxes, depreciation, and amortization of AU$1.4 million, an improvement from a AU$3.3 million loss in the year-ago period.Mayne Pharma said it continues to evaluate capital allocation strategies, including a potential on-market share repurchase.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","BK7508","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150217046","title":"Stock Track | Mayne Pharma Group Soars 5.58% Intraday on Strong Revenue, Tariff Immunity and Buy-Back Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=1150217046","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150217046?lang=en_us&edition=fundamental","pubTime":"2026-04-29 08:17","pubTimestamp":1777421842,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group Ltd's stock surged 5.58% during intraday trading on Wednesday, marking a significant upward movement for the pharmaceutical company.The sharp rise appears to be driven by several...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631530545","title":"Mayne Pharma Group Ltd: No Material Earnings Impact From US Tariff Proclamation on 7 April","url":"https://stock-news.laohu8.com/highlight/detail?id=2631530545","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631530545?lang=en_us&edition=fundamental","pubTime":"2026-04-29 07:33","pubTimestamp":1777419228,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B152:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","MYX.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631530528","title":"Mayne Pharma Group - Continues to Examine Capital Allocation Strategies, May Include on-Market Share Buy-Back","url":"https://stock-news.laohu8.com/highlight/detail?id=2631530528","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631530528?lang=en_us&edition=fundamental","pubTime":"2026-04-29 07:33","pubTimestamp":1777419228,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B152:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627230683","title":"Maywood Acquisition Closes $100 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2627230683","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627230683?lang=en_us&edition=fundamental","pubTime":"2026-04-16 04:26","pubTimestamp":1776284780,"startTime":"0","endTime":"0","summary":"Maywood Acquisition  said late Wednesday it has completed its initial public offering of 10 million units at $10 per unit, resulting in gross proceeds of $100 million.Its units are listed on Nasdaq under the symbol \"MYXXU\".Each unit consists of one Class A ordinary share, one right entitling the holder to receive one-fourth of one Class A ordinary share upon the completion of an initial business combination, and one warrant to purchase one Class A ordinary share for $11.50 per share, subject to adjustment, according to the company.Once the securities comprising the units begin trading separately, the ordinary shares, rights and warrants are expected to be listed on Nasdaq under the symbols \"MYX,\" \"MYXXR\" and \"MYXXW,\" respectively.An aggregate of $100 million from IPO net proceeds and a simultaneous private placement of units was placed in a trust, the company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","MYX.AU","SPCX","IPOS","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":50,"code":"91000000","status":"200"}]}}